Trump administration may go beyond drug price blueprint

Recent drug price increases are prompting the Trump administration to consider taking steps that go beyond the drug pricing blueprint it released in May, John O’Brien, adviser to the HHS secretary and deputy assistant secretary for health policy, said Tuesday.

Speaking at

Read the full 420 word article

User Sign In